EGFR and cancer: A population of putative cancer stem cells with enhanced sphere-forming ability, reduced sensitivity to radiation and conventional chemotherapy, and demonstrated resistance to gefitinib (EGFR-targeting drug) has also been demonstrated in FOSCC [50].